Human Cells anti-COVID-19 S-IgM Neutralizing Antibody
Product Specifications
Background
Human monoclonal neutralizing antibody to COVID-19 S protein
CAS Number
9007-83-4
Synonyms
Spike glycoprotein; S glycoprotein; E2; Peplomer protein
Host
Human Cells
Reactivity
COVID-19
Clonality
Monoclonal
Applications
E
Purification Method
>95%, cultured in vitro under conditions free from animal derived components.
Concentration
1mg/mL
Dilution
ELISA: Use at an assay dependent dilution.
Buffer
1 mg/ml. Human IgM. Liquid in 0.01M Phosphate Buffered Saline, pH 7.4.
Storage Conditions
Shipped at 4°C. Upon delivery aliquot and store at -20°C for one year. Avoid freeze/thaw cycles.
WB Description
Immobilized Recombinant COVID-19 S Protein RBD-SD1 (Cat#CRP3097) at 5 ug/ml can bind Anti-COVID-19 S-IgM Neutralizing Antibody, the EC50 is less than 18.5 ng/ml.
IHC description
Anti-COVID-19 S-IgM Neutralizing Antibody can block Recombinant Human ACE2 Protein (Cat#CRP1003) and Recombinant COVID-19 S Protein RBD-SD1 (Cat#CRP3097) interaction, the IC50 for this effect is 83.9 ng/ml.
Gene ID (Human)
43740568
SwissProt (Human)
P0DTC2
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC880181-100 1x 100 µL
CD59 (heavy chain of Protectin) (BRA-10G), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC881081-100 1x 100 µL
CD45RO (190-2F2.5), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC681777-500 1x 500 µL
Prostate Specific Antigen (PSA) (3E6), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details